论文部分内容阅读
我们观察由靖江制药厂提供的“心痛康”胶囊治疗363例冠心病心绞痛,取得较好疗效,现报道如下: 1 对象与方法 1.1 观察对象:所有验证病例均需符合下列标准: (1)WHO规定的心绞痛范围;(2)心电图有缺血性ST段表现,静息心电图ST段下降>0.05mV,踏车运动试验ST段下降≥0.10mV。 1.2 观察方法:入选的363例患者先停用任何治疗心绞痛的药物二周。进行病史采集、体
We observe the “Jingtongkang” capsule provided by Jingjiang Pharmaceutical Factory to treat 363 cases of coronary heart disease with angina pectoris and achieve better curative effect. The reports are as follows: 1 Subjects and Methods 1.1 Observation Subjects: All validated cases should meet the following criteria: (1) WHO (2) ECG showed ischemic ST segment performance, resting ST segment depression> 0.05mV, treadmill exercise test ST segment decreased ≥ 0.10mV. 1.2 Methods of observation: selected 363 patients to disable any treatment of angina drugs for two weeks. Medical history collection, body